Archives

Use the basic search or click on advanced for more search options.

Advanced Search Basic Search Advanced Search

Publications

Section

Select publication to see the relevant sections.

Publication Date

    E.g., 2018-10-21
    E.g., 2018-10-21

Archive Search

1 results
1:03 PM, Dec 08, 2017  |  BC Week In Review | Company News  |  Deals

Newco Ayala in-licenses BMS gamma secretase inhibitors

Co. (NYSE:BMY) granted newco Ayala Pharmaceuticals Inc. (Rehovot, Israel) exclusive, worldwide rights to BMS-906024 and BMS-986115
adenoid cystic carcinoma and an undisclosed Orphan indication. Gelbaum declined to disclose next steps for BMS-986115
which has completed Phase Ib testing. BMS-906024 is administered by IV, while BMS-986115 is an oral …